Thermo Fisher Completes $8.875 Billion Acquisition of Clario Holdings

On March 24, 2026, Thermo Fisher Scientific Inc. announced the completion of its acquisition of Clario Holdings, Inc. for $8.875 billion in cash, with additional performance-dependent earnouts. The Clario business will enhance Thermo Fisher's Laboratory Products and Biopharma Services segment. It is projected to contribute $0.45 to adjusted EPS in its first year and generate approximately $175 million in adjusted operating income from synergies by year five. This acquisition is expected to drive high single-digit growth in Clario’s business and improve operating margins for Thermo Fisher.

Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.